Cardiovascular disease and cancer are the 2 leading causes of death worldwide. Emerging
evidence suggests common mechanisms between cancer and cardiovascular disease …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Cardiovascular (CV) events in patients with cancer can be caused by concomitant CV risk
factors, cancer itself, and anticancer therapy. Since malignancy can dysregulate the …

Cancer patients have an increased risk of cardiovascular disease and, notably, a significant
prevalence of acute coronary syndrome (ACS). It has been shown that an elevated presence …

Young patients who underwent percutaneous coronary intervention (PCI) have shown
worse long-term outcomes but remain inadequately investigated. We analyzed 1,186 …

Abstract Background Myeloproliferative neoplasms (MPNs) are hematopoietic stem cell
neoplasms with a high risk of thrombosis, including acute myocardial infarction (AMI) …

Background To investigated the prognosis of the most prevalent cancers (breast-,
gastrointestinal-, and lung cancer), according to cancer status (ie, active-, non-active …

Cardiologists are encountering a growing number of cancer patients with ischaemic heart
disease (IHD). Several factors account for the interrelationship between these two …

The development of cardiovascular toxicity attributable to anticancer drugs is a pivotal event
that is associated with cardiovascular morbidity as well as with worse cancer‐specific and …

Publications in cardio-oncology have increased exponentially over the past two decades.
The Year in Cardiovascular Medicine: Cardio-Oncology 2020–21 covers the most recent …